Navigation Links
Idenix to Host Conference Call Discussing Fourth Quarter 2008 Financial Results
Date:2/11/2009

CAMBRIDGE, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX) announced today that it will report its financial results for the fourth quarter of 2008 on Tuesday, February 17, 2009 after the U.S. financial markets close.

In conjunction with the issuance of the press release, Idenix management will host a conference call at 4:30 p.m. ET on Tuesday, February 17, 2009 to discuss the company's financial results for the fourth quarter of 2008.

To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and enter passcode 84153140 or to listen to a live audio webcast of the call, go to "Calendar of Events" in the Idenix Investor Center at www.idenix.com. A replay of the call will also be available from 7:30 p.m. ET on February 17, 2009 until March 4, 2009 12:00 a.m. ET. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 84153140. An archived webcast will also be available for two weeks after the call on the Idenix website.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.

    Amy Sullivan 617-995-9838 (investors)
    Teri Dahlman 617-995-9905 (media)


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals to Present at the JP Morgan 27th Annual Healthcare Conference
2. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
3. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
4. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
5. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
6. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
7. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
8. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
9. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
11. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, today presented ... compound, napabucasin, at the 2017 American Society of Clinical ... Francisco . In a Phase ... agent designed to inhibit cancer stemness pathways by targeting ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
(Date:1/19/2017)... , Jan 19, 2017 Research and Markets ... Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis and ... ... that the global market is projected to reach $15,737 million by ... from 2016 to 2022. Omic technologies segment accounted ...
(Date:1/19/2017)... Jan. 19, 2017 /PRNewswire -- WuXi AppTec, a ... capability and technology platform, today announced that it ... focused preclinical drug discovery contract research organization (CRO). ... a wholly-owned subsidiary of WuXi, and will continue ... providing greater services. The acquisition will further strengthen ...
Breaking Biology Technology:
(Date:1/19/2017)... CLARA, Calif. , Jan. 19, 2017 /PRNewswire/ ... company enhancing user experience and security for consumer ... of next-generation payment processing systems and cybersecurity solutions, ... more banks, enterprises and financial institutions worldwide to ... part of the end-to-end secure user authentication platforms ...
(Date:1/13/2017)... PORT WASHINGTON, N.Y. , Jan. 13, 2017 ... provider of technology solutions for the homecare industry, ... appointment of homecare industry expert, Justin Jugs, as ... Justin brings more than 15 years of homecare ... the team in developing strategic plans to align ...
(Date:1/12/2017)... 2017 A new report by Allied Market Research, titled, "Global ... technology market is expected to generate revenue of $10.72 billion by 2022, with an ... Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In the year ...
Breaking Biology News(10 mins):